Navigation Links
FusionHealth Supports FAA’s New Policy To Detect And Treat Obstructive Sleep Apnea (OSA) Among Pilots And Controllers

Atlanta, GA (PRWEB) November 21, 2013

FusionHealth®, the leading provider of innovative sleep health management solutions that improve employee health and wellness by preventing chronic diseases and reducing costs directly linked to sleep disorders today commends the FAA on its new policy to detect and treat obstructive sleep apnea among pilots and controllers, as outlined here in an article by CNN on Wednesday, November 20, 2013. Significant health, safety and economic benefits are associated with sleep apnea treatment and made possible by technology-enabled sleep health management solutions, such as the Sleep4YourHealth program available anywhere in the U.S. via the FusionHealth i.AIM® Platform.

FusionHealth’s Sleep4YourHealth end-to-end sleep health management solution for employers is designed to accomplish precisely what the FAA is looking to do. The Sleep4YourHealth solution allows the deployment of comprehensive sleep health management programs to business associates - such as pilots and air traffic controllers - and seamlessly delivers superior levels of engagement and adherence using various corrective sleep therapies. In addition, FusionHealth’s solutions are cost effective and drive a measurable return on investment to the bottom line.

The FAA announced it would begin its program by testing pilots with a body mass index (BMI) of more than 40 and neck size larger than 17 inches, to determine if they suffer from OSA. Clinical data suggests that there is a strong correlation between a high BMI and Obstructive Sleep Apnea. Eventually, the FAA plans to lower the BMI threshold to 30, and will include air traffic controllers in the detection and treatment program.

“Not only are obese people more prone to suffer from OSA, data now suggests that the presence of OSA contributes to obesity itself,” stated Dr. Jeffrey Durmer, Co-Founder and Chief Medical Officer of Fusion Health, and Sleep Medicine Counsel to the FAA. “We’ve been helping companies in the transportation industry successfully deal with this critically important health issue for many years. From our clinical experience as well as years of research, we know that the key to success for any OSA program is adherence to sleep treatments. Our innovative technology-enabled care management approach has been very successful in attaining unparalleled levels of adherence to long-term effective treatments.”

About FusionHealth
FusionHealth®, headquartered in Atlanta, GA, delivers technology-enabled integrated sleep health management solutions for companies seeking to improve employee health and reduce health-related costs. The company’s SaaS-based delivery model provides its client companies with access to its global technology platform enabling them to integrate sleep health management with personal wellness and employee engagement in a way that changes lives and improves their bottom line performance. For more information, visit

Company Contact
Craig Reamsnyder                
EVP Business Development, FusionHealth
888-505-0280 - cr(at)fusionhealth(dot)com    
P.R. Contact
Randy Salisbury
Marketing & Communications, FusionHealth
404-229-4242 - rsalisbury(at)fusionhealth(dot)com

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. FusionHealth to Present at The North American Transportation Employee Relations Conference (NATERA)
2. FusionHealth Unveils New Technology to Expand its Sleep4YourHealth® Sleep Health Management Solution
3. FusionHealth Receives HealthCare Consumerism Superstar Industry Innovator Award
4. Study Supports Value of Sigmoidoscopy, an Alternative to Colonoscopy
5. Study supports urate protection against Parkinsons disease, hints at novel mechanism
6. Dietary fiber alters gut bacteria, supports gastrointestinal health
7. Narconon Louisiana Supports United Nations International Day Against Drug Abuse and Illicit Trafficking
8. NIDA supports development of combined anti-heroin and HIV vaccine
9. Little evidence supports autism treatment options in adolescents
10. $1.8 million grant supports investigation of psoriasis link to cardiovascular disease
11. John Templeton Foundation grant supports Princeton neuroscientists to study cognitive control
Post Your Comments:
(Date:11/28/2015)... ... , ... Safe storage for contraceptive devices may not always be easy to ... and the other from Bradley Beach, New Jersey, there is an easy solution to ... to replace NuvaRings more often than necessary. As such, it affords peace of mind ...
(Date:11/27/2015)... ... November 28, 2015 , ... There is only one major question facing ... last year? , This question has not been an easy question to answer. Especially ... age and the younger workforce don’t share the same discipline around working long hours. ...
(Date:11/27/2015)... ... 27, 2015 , ... The rapid speed at which Americans ... more care is needed, especially with Alzheimer’s, dementia and other cognitive conditions becoming ... The forgotten part of this equation: 80 percent of medical care occurs in ...
(Date:11/27/2015)... ... 27, 2015 , ... Lizzie’s Lice Pickers just announced a special promotion that ... of their purchase of lice treatment product. In addition, customers will receive a complimentary ... spokesperson. “Finding lice is a sure way to ruin the holidays, so we encourage ...
(Date:11/27/2015)... , ... November 27, 2015 , ... ... of progress through sharing, the 2016 Building Better Radiology Marketing Programs ... will begin on Sunday, March 6, 2016, at Caesars Palace in Las Vegas ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... Nov. 26, 2015 Research and Markets ... the "2016 Future Horizons and Growth Strategies ... Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging ... --> --> This ... the Italian therapeutic drug monitoring market, including emerging ...
(Date:11/25/2015)... , Nov. 25, 2015  Amgen (NASDAQ: AMGN ... Application (BLA) with the United States ... 501, a biosimilar candidate to Humira ® (adalimumab). ... application submitted to the FDA and represents Amgen,s first ... Sean E. Harper , M.D., executive vice president of ...
(Date:11/25/2015)... Nov. 25, 2015  ARKRAY USA ... to provide evidence demonstrating the accuracy of its blood ... on Insulin Resistance, Diabetes and Cardiovascular Disease in ... the Company,s GLUCOCARD ® 01 meter and the ... requirements. The ability to accurately measure glucose levels in ...
Breaking Medicine Technology: